OpenFilings

Jazz Pharmaceuticals plc

Form10-Q

Report Period2025-06-30

Date Filed2025-08-06

Time Filed07:33:51

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
LICENSE AND OPTION AGREEMENT
AMENDED AND RESTATED LICENSE AND OPTION AGREEMENT
LETTER AGREEMENT
CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
Filing on SEC Edgar